1. Home
  2. CMPX vs NGL Comparison

CMPX vs NGL Comparison

Compare CMPX & NGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.53

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Logo NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests

NGL

NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests

HOLD

Current Price

$9.77

Market Cap

751.7M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPX
NGL
Founded
2014
1940
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
752.4M
751.7M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
CMPX
NGL
Price
$5.53
$9.77
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$13.44
N/A
AVG Volume (30 Days)
2.2M
444.4K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,250,313,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
46.95
52 Week Low
$1.33
$2.64
52 Week High
$5.86
$10.29

Technical Indicators

Market Signals
Indicator
CMPX
NGL
Relative Strength Index (RSI) 67.47 62.55
Support Level $5.13 $9.45
Resistance Level $5.86 $10.13
Average True Range (ATR) 0.32 0.41
MACD 0.03 -0.13
Stochastic Oscillator 72.12 64.29

Price Performance

Historical Comparison
CMPX
NGL

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

Share on Social Networks: